Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immunogen Inc (NQ: IMGN ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Feb 9, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Immunogen Inc < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 03, 2023 From ImmunoGen, Inc. Via Business Wire 5 Sizzling Stocks That Are Outperformers in the Market This Year July 02, 2023 Looking for the top-performing stocks and market outperformers? Discover the hot stocks to buy and maximize your investment potential. Via InvestorPlace MoonLake Immunotherapeutics Makes a Moonshot on Trials June 28, 2023 Clinical-stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive clinical trial results. Via MarketBeat Exposures Product Safety ImmunoGen Stock Continues to Defy Gravity on Phase 2 Trials June 26, 2023 ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles t Via MarketBeat Midcap Biotech Stock ImmunoGen is Shooting Higher Today: Here's Why June 09, 2023 ImmunoGen Inc (NASDAQ: IMGN) announced updated Via Benzinga The Latest Analyst Ratings for Immunogen June 06, 2023 Via Benzinga Truist Securities Maintains Buy Rating for Immunogen: Here's What You Need To Know June 06, 2023 Via Benzinga Mersana's UpRi Shows Potential in Ovarian Cancer; Analyst Initiates Coverage with Buy Rating June 15, 2023 Guggenheim Partners has initiated coverage on Mersana Therapeutics Inc (NASDAQ: MRSN) with a Buy rating Via Benzinga Tesla, Adobe, Mission Produce And Other Big Stocks Moving Higher On Friday June 09, 2023 U.S. stocks traded higher, with the Dow Jones rising around 100 points on Friday. Here are some big stocks recording gains in today’s session. Braze, Inc. (NASDAQ: BRZE) shares climbed 20.4% to $ 40.82... Via Benzinga Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review June 09, 2023 The Nasdaq held near 52-week highs while small caps ramped up. Via Investor's Business Daily ImmunoGen Presents Updated Findings from CADENZA Trial of Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm at EHA 2023 Congress June 09, 2023 From ImmunoGen Inc. Via Business Wire Midcap Biotech Stock ImmunoGen is Shooting Higher Today: Here's Why June 05, 2023 Via Benzinga Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 05, 2023 Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding. Via Benzinga ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes June 05, 2023 ImmunoGen and Day One gained Monday on their updates at a cancer treatment conference. Via Investor's Business Daily Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday June 05, 2023 It's time to start the week off right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! Via InvestorPlace Day One Biopharmaceuticals, ImmunoGen And Other Big Stocks Moving Higher In Monday's Pre-Market Session June 05, 2023 U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. Via Benzinga ELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FRα-Positive Platinum-Resistant Ovarian Cancer June 04, 2023 From ImmunoGen Inc. Via Business Wire AI Boom Wanes In June: Nvidia Falls Under $1T As Benzinga Reviews May's Champions June 01, 2023 Via Benzinga ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 01, 2023 From ImmunoGen, Inc. Via Business Wire Promising Developments Announced Ahead of 2023 ASCO Annual Meeting’s Oral Presentations May 26, 2023 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:IMGN),(NASDAQ:DAWN),(NASDAQ:LEGN) EQNX::TICKER_END Via FinancialNewsMedia Exposures Product Safety 10 Health Care Stocks With Whale Alerts In Today's Session May 25, 2023 Via Benzinga ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Jefferies Healthcare Conference May 24, 2023 From ImmunoGen, Inc. Via Business Wire Stocks Stumble, Weekly Wins Still In Sight May 19, 2023 Stocks are lower midday, paring solid gains from the morning. Despite stumbling into the weekend, all three major indexes are heading toward comfy weekly wins. Via Talk Markets 3 Biotech Stocks That Are Revolutionizing Healthcare in 2023 May 19, 2023 Here are three of the best biotech stocks to buy; each is on the verge of significant breakthroughs that may send the price higher. Via InvestorPlace MarketBeat Week in Review – 5/8 - 5/12 May 13, 2023 Inflation, bank woes, interest rates, and the debt ceiling led to more of the new normal for equity markets. Here are some of this week's most popular articles Via MarketBeat Topics Economy Electric Vehicles Exposures Electric Vehicles Interest Rates ImmunoGen Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares May 09, 2023 From ImmunoGen, Inc. Via Business Wire ImmunoGen Announces Results from the Phase 3 MIRASOL Trial Selected as Late-Breaking Presentation for ASCO 2023 Annual Meeting May 09, 2023 From ImmunoGen, Inc. Via Business Wire 10 Health Care Stocks With Whale Alerts In Today's Session May 08, 2023 Via Benzinga ImmunoGen Nearly Triples on Ovarian Cancer Drug Phase 3 Results May 08, 2023 Commercial-state biotechnology company ImmunoGen Inc. (NASDAQ: IMGN) shares more than doubled on phase 3 clinical trial results. Its ovarian cancer drug Via MarketBeat ImmunoGen Announces Pricing of Upsized Public Offering of Common Stock May 04, 2023 From ImmunoGen Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.